Khor Sinan, Cai Dongsheng
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A.
Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A.
Clin Sci (Lond). 2017 Feb 1;131(3):211-223. doi: 10.1042/CS20160001.
Hypertension is a major health problem with great consequences for public health. Despite its role as the primary cause of significant morbidity and mortality associated with cardiovascular disease, the pathogenesis of essential hypertension remains largely unknown. The central nervous system (CNS) in general, and the hypothalamus in particular, are intricately involved in the development and maintenance of hypertension. Over the last several decades, the understanding of the brain's role in the development of hypertension has dramatically increased. This brief review is to summarize the neural mechanisms of hypertension with a focus on neuroendocrine and neurotransmitter involvement, highlighting recent findings that suggest that hypothalamic inflammation disrupts key signalling pathways to affect the central control of blood pressure, and therefore suggesting future development of interventional strategies that exploit recent findings pertaining to the hypothalamic control of blood pressure as well as the inflammatory-sympathetic mechanisms involved in hypertension.
高血压是一个重大的健康问题,对公众健康有严重影响。尽管它是与心血管疾病相关的重大发病和死亡的主要原因,但其发病机制仍不清楚。一般来说,中枢神经系统(CNS),尤其是下丘脑,与高血压的发生和维持密切相关。在过去几十年中,对大脑在高血压发生中的作用的理解有了显著增加。这篇简短的综述旨在总结高血压的神经机制,重点关注神经内分泌和神经递质的参与,强调最近的研究结果,即下丘脑炎症会破坏关键信号通路,从而影响血压的中枢控制,因此提出未来干预策略的发展方向,即利用与下丘脑对血压的控制以及高血压中涉及的炎症-交感神经机制相关的最新研究成果。